A US court ruling finds reporting of many clinical trials of unapproved drugs in breach of the law. But responses to the ruling are uncertain.
Less than half of trials on clinicaltrials.gov meet the FDAAA results reporting deadline in a study from Ben Goldacre’s EBM DataLab at Oxford University
AllTrials seeks support for a new initiative to monitor clinical trial reporting in the UK.
Missed ISMPP EU 2019? Read our meeting report to get up to speed!
A new study from the AllTrials team sheds light on clinical trial reporting rates by non-industry sponsors.
A new, regular series in The BMJ will highlight a different unreported clinical trial every week, with the intention of improving reporting rates.
The FDAAA 2007 requires clinical trials to make results publicly available 12 months after study completion. A new tool from TrialsTracker provides a live online report on compliance.